Carsten Tschöpe, Enrico Ammirati, Biykem Bozkurt, Alida L P Caforio, Leslie T Cooper, Stephan B Felix, Joshua M Hare, Bettina Heidecker, Stephane Heymans, Norbert Hübner, Sebastian Kelle, Karin Klingel, Henrike Maatz, Abdul S Parwani, Frank Spillmann, Randall C Starling, Hiroyuki Tsutsui, Petar Seferovic, Sophie Van Linthout
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the myocardium and a high risk of deteriorating cardiac function, has a heterogeneous aetiology. Inflammatory cardiomyopathy is predominantly mediated by viral infection, but can also be induced by bacterial, protozoal or fungal infections as well as a wide variety of toxic substances and drugs and systemic immune-mediated diseases. Despite extensive research, inflammatory cardiomyopathy complicated by left ventricular dysfunction, heart failure or arrhythmia is associated with a poor prognosis...
March 2021: Nature Reviews. Cardiology